Pleural Effusion Caused by Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

被引：2
|
作者：
Rachakonda, Tara [1 ]
Kendall, Brian [2 ]
Spivak, Adam M. [2 ]
Boltax, Jonathan [3 ]
机构：
[1] Univ Utah Hosp & Clin, Dept Med, Salt Lake City, UT USA
[2] Univ Utah Hosp & Clin, Div Infect Dis, Salt Lake City, UT USA
[3] Univ Utah Hosp & Clin, Div Pulm Med, Salt Lake City, UT USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2017年 / 4卷 / 03期
关键词：
bacillus Calmette Guerin; bladder cancer; pleural effusion; INTRAVESICAL THERAPY; BCG INFECTION; COMPLICATIONS;
D O I：
10.1093/ofid/ofx126
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Intravesical bacillus Calmette Guerin (BCG) instillation has been used as immunotherapy for early stage bladder cancer for >40 years. Complications from this therapy are rare but may result in a spectrum of infectious sequelae. Here we describe the case of an elderly man who presented with a pleural effusion and subcutaneous nodule several years after treatment with BCG.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Bacillus Calmette-Guerin in the management of superficial bladder cancer
    Kapoor, Rakesh
    Vijjan, Vivek
    Singh, Pratipal
    [J]. INDIAN JOURNAL OF UROLOGY, 2008, 24 (01) : 72 - 76
  • [32] Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy
    Zheng, Yuan-qiang
    Naguib, Youssef W.
    Dong, Yixuan
    Shi, Yan-chun
    Bou, Shorgan
    Cui, Zhengrong
    [J]. EXPERT REVIEW OF VACCINES, 2015, 14 (09) : 1255 - 1275
  • [33] HUMAN GENE POLYMORPHISM AND RESPONSE TO BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR SUPERFICIAL BLADDER CANCER
    Chiong, E.
    Kesavan, A.
    Mahendran, R.
    Chan, Y. H.
    Tan, T. M. C.
    Esuvaranathan, K.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 261 - 261
  • [34] Re: History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story Reply
    不详
    [J]. JOURNAL OF UROLOGY, 2008, 180 (05): : 2255 - 2255
  • [35] Human gene polymorphism and response to Bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
    Chiong, Edmund
    Kesavan, Arshvin
    Mahendran, Ratha
    Chan, Yiong Huak
    Tan, Theresa M. C.
    Esuvaranathan, Kesavan
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 614 - 614
  • [36] Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer
    Liu, Yuqing
    Lu, Jian
    Huang, Yi
    Ma, Lulin
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [37] Emerging Immunotherapy Options for bacillus Calmette-Guerin Unresponsive Nonmuscle Invasive Bladder Cancer
    Meng, Maxwell V.
    Gschwend, Juergen E.
    Shore, Neal
    Grossfeld, Gary D.
    Mostafid, Hugh
    Black, Peter C.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (06): : 1111 - 1119
  • [38] Human gene polymorphism and response to bacillus calmette-guerin immunotherapy for superficial bladder cancer
    Chiong, E.
    Mahendran, R.
    Esuvaranathan, K.
    Kesavan, A.
    Chan, Y. H.
    Tan, T. M. C.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A292 - A292
  • [39] Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma
    Cugati, Sudha
    Gilhotra, Jagjit Singh
    Lake, Stewart
    Gordon, David L.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 (05): : 494 - 495
  • [40] Bladder sparing landscape for Bacillus Calmette-Guerin unresponsive bladder cancer
    Soria, Francesco
    Giordano, Andrea
    Shariat, Shahrokh F.
    Gontero, Paolo
    [J]. CURRENT OPINION IN UROLOGY, 2020, 30 (04) : 542 - 546
12345